260 related articles for article (PubMed ID: 26778342)
1. Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases.
Hiraga T
Expert Opin Investig Drugs; 2016; 25(3):319-34. PubMed ID: 26778342
[TBL] [Abstract][Full Text] [Related]
2. Emerging therapies in bone metastasis.
Clément-Demange L; Clézardin P
Curr Opin Pharmacol; 2015 Jun; 22():79-86. PubMed ID: 25935860
[TBL] [Abstract][Full Text] [Related]
3. Emerging drugs for the treatment of bone metastasis.
Pantano F; Iuliani M; Zoccoli A; Fioramonti M; De Lisi D; Fioroni I; Ribelli G; Santoni M; Vincenzi B; Tonini G; Santini D
Expert Opin Emerg Drugs; 2015; 20(4):637-51. PubMed ID: 26113304
[TBL] [Abstract][Full Text] [Related]
4. Future treatment of bone metastases.
Lipton A
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6305s-6308s. PubMed ID: 17062719
[TBL] [Abstract][Full Text] [Related]
5. Basic and clinical associations between bone and cancer.
He F; Matsumoto Y
Immunol Med; 2020 Sep; 43(3):103-106. PubMed ID: 32301686
[TBL] [Abstract][Full Text] [Related]
6. [Encounter of cancer cells with bone. Development of bone metastasis-specific targeting therapy].
Hayashi S; Hanamura T
Clin Calcium; 2011 Mar; 21(3):389-96. PubMed ID: 21358060
[TBL] [Abstract][Full Text] [Related]
7. A multi-targeted approach to treating bone metastases.
Camacho DF; Pienta KJ
Cancer Metastasis Rev; 2014 Sep; 33(2-3):545-53. PubMed ID: 24390423
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in bone-targeted therapies of metastatic prostate cancer.
Deng X; He G; Liu J; Luo F; Peng X; Tang S; Gao Z; Lin Q; Keller JM; Yang T; Keller ET
Cancer Treat Rev; 2014 Jul; 40(6):730-8. PubMed ID: 24767837
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications.
De Castro J; García R; Garrido P; Isla D; Massuti B; Blanca B; Vázquez J
Clin Lung Cancer; 2015 Nov; 16(6):431-46. PubMed ID: 26264596
[TBL] [Abstract][Full Text] [Related]
10. Advances in prevention and treatment of bone metastases in prostate cancer. Role of RANK/RANKL inhibition.
Gomez-Veiga F; Ponce-Reixa J; Martinez-Breijo S; Planas J; Morote J
Actas Urol Esp; 2013 May; 37(5):292-304. PubMed ID: 23246105
[TBL] [Abstract][Full Text] [Related]
11. Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer.
Msaouel P; Nandikolla G; Pneumaticos SG; Koutsilieris M
Expert Opin Investig Drugs; 2013 Nov; 22(11):1385-400. PubMed ID: 24024652
[TBL] [Abstract][Full Text] [Related]
12. The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease.
Turner CJ; Edwards CM
Curr Osteoporos Rep; 2016 Oct; 14(5):170-7. PubMed ID: 27566487
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases.
Whang YM; Jung SP; Kim MK; Chang IH; Park SI
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658428
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic targets for bone metastases in breast cancer.
Clézardin P
Breast Cancer Res; 2011 Apr; 13(2):207. PubMed ID: 21586099
[TBL] [Abstract][Full Text] [Related]
15. Emerging therapies in metastatic bone pain.
Coluzzi F; Mandatori I; Mattia C
Expert Opin Emerg Drugs; 2011 Sep; 16(3):441-58. PubMed ID: 21545247
[TBL] [Abstract][Full Text] [Related]
16. [Bone metastases of breast cancer].
Hata K; Yoneda T
Clin Calcium; 2014 Aug; 24(8):1177-84. PubMed ID: 25065869
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates and their impact on disseminated tumor cells in early stage breast cancer.
Li J; Rugo HS
Breast Dis; 2011; 33(2):83-92. PubMed ID: 22142661
[TBL] [Abstract][Full Text] [Related]
18. Dynamic modeling of bone metastasis, microenvironment and therapy: Integrating parathyroid hormone (PTH) effect, anti-resorptive and anti-cancer therapy.
Coelho RM; Lemos JM; Alho I; Valério D; Ferreira AR; Costa L; Vinga S
J Theor Biol; 2016 Feb; 391():1-12. PubMed ID: 26657065
[TBL] [Abstract][Full Text] [Related]
19. Bone-Targeted Therapies in Cancer-Induced Bone Disease.
Sousa S; Clézardin P
Calcif Tissue Int; 2018 Feb; 102(2):227-250. PubMed ID: 29079995
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of bisphosphonates in cancer therapy.
Lüftner D; Henschke P; Possinger K
Anticancer Res; 2007; 27(4A):1759-68. PubMed ID: 17649770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
